Predilife (ALPRE) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.219x

Based on the latest financial reports, Predilife (ALPRE) has a cash flow conversion efficiency ratio of 0.219x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.28 Million ≈ $-1.49 Million USD) by net assets (€-5.82 Million ≈ $-6.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Predilife - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Predilife's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Predilife (ALPRE) total liabilities for a breakdown of total debt and financial obligations.

Predilife Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Predilife ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Magna Terra Minerals Inc
V:MTT
-0.706x
AIR INDUSTRIES GR.DL-001
F:YH1
N/A
Sarama Resources Ltd
AU:SRR
1.779x
Tecom Co Ltd
TW:2321
-0.015x
Multi Prima Sejahtera Tbk
JK:LPIN
-0.008x
Desenio Group AB
ST:DSNO
0.087x
TEAM PLC
F:1WQ
N/A
IDT Australia Ltd
AU:IDT
-0.047x

Annual Cash Flow Conversion Efficiency for Predilife (2016–2024)

The table below shows the annual cash flow conversion efficiency of Predilife from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see ALPRE market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €-4.27 Million
≈ $-4.99 Million
€-3.72 Million
≈ $-4.35 Million
0.872x +110.59%
2023-12-31 €513.52K
≈ $600.36K
€-4.23 Million
≈ $-4.94 Million
-8.236x -1502.63%
2022-12-31 €-5.22 Million
≈ $-6.10 Million
€-3.07 Million
≈ $-3.58 Million
0.587x -75.98%
2021-12-31 €-1.57 Million
≈ $-1.83 Million
€-3.83 Million
≈ $-4.47 Million
2.445x +183.67%
2020-12-31 €721.69K
≈ $843.73K
€-2.11 Million
≈ $-2.47 Million
-2.922x -193.26%
2019-12-31 €-764.29K
≈ $-893.53K
€-2.39 Million
≈ $-2.80 Million
3.133x -97.90%
2018-12-31 €-12.10K
≈ $-14.15K
€-1.81 Million
≈ $-2.11 Million
149.479x +12560.50%
2017-12-31 €-1.29 Million
≈ $-1.51 Million
€-1.53 Million
≈ $-1.78 Million
1.181x +131.59%
2016-12-31 €362.63K
≈ $423.95K
€-1.36 Million
≈ $-1.58 Million
-3.737x --

About Predilife

PA:ALPRE France Diagnostics & Research
Market Cap
$13.66 Million
€11.68 Million EUR
Market Cap Rank
#26377 Global
#454 in France
Share Price
€2.98
Change (1 day)
+0.00%
52-Week Range
€2.96 - €4.29
All Time High
€15.90
About

Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer pred… Read more